Plan Group Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Sell
1,491
-25
-2% -$5.38K 0.08% 148
2026
Q1
$330K Buy
1,516
+201
+15% +$44.6K 0.08% 160
2025
Q4
$300K Sell
1,315
-248
-16% -$56.5K 0.08% 153
2025
Q3
$362K Buy
1,563
+91
+6% +$18.5K 0.1% 131
2025
Q2
$273K Buy
1,472
+165
+13% +$30.7K 0.09% 135
2025
Q1
$274K Buy
+1,307
New +$254K 0.1% 122
2023
Q3
Sell
-4,914
Closed -$674K 72
2023
Q2
$674K Buy
+4,914
New +$721K 0.56% 31

Other funds holding ABBV

Plan Group Financial's ABBV Position: Q2 2026 in Review

Plan Group Financial reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $5.38K and leaving 1,491 shares worth $375K. The position accounts for 0.08% of the portfolio, ranked #148.

Plan Group Financial first reported a position in ABBV in Q2 2023 and has held it in 7 quarters since. The position peaked at $674K in Q2 2023. 4,218 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Plan Group Financial held 1,491 shares of AbbVie worth $375K as of Q2 2026.
  • Plan Group Financial sold 25 AbbVie shares in Q2 2026, an estimated $5.38K.
  • AbbVie made up 0.08% of Plan Group Financial's portfolio in Q2 2026, its #148 holding.
  • Plan Group Financial first reported a position in AbbVie in Q2 2023 and has held it in 7 quarters since.
  • Plan Group Financial's AbbVie position peaked at $674K in Q2 2023.
  • 4,218 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Plan Group Financial's 13F filing for Q2 2026, filed 3 Aug 2026.